NASDAQ:TMDI - Titan Medical Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $4.00
  • Forecasted Upside: 135.29 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$1.70
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New Titan Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TMDI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TMDI

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$4.00
▲ +135.29% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Titan Medical in the last 3 months. The average price target is $4.00, with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 135.29% upside from the last price of $1.70.
Buy
The current consensus among 1 polled investment analysts is to buy stock in Titan Medical. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/21/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/19/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/18/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/17/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/15/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/13/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/14/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/13/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/13/2021OppenheimerInitiated CoverageOutperform$4.00N/A
i
4/6/2021OppenheimerInitiated CoverageOutperform$4.00High
i
4/2/2020Maxim GroupReiterated RatingHoldHigh
i
4/1/2020Piper SandlerLower Price Target$1.50 ➝ $1.00Medium
i
12/23/2019Piper Jaffray CompaniesReiterated RatingBuy$2.50 ➝ $1.50Medium
i
Rating by Adam Maeder at Piper Jaffray Companies
11/18/2019Piper Jaffray CompaniesReiterated RatingBuy$2.50High
i
Rating by Adam Maeder at Piper Jaffray Companies
10/16/2019Maxim GroupDowngradeBuy ➝ HoldHigh
i
7/18/2019Northland SecuritiesReiterated RatingBuyLow
i
5/22/2019Piper Jaffray CompaniesInitiated CoverageOverweight$6.00 ➝ $6.00High
i
2/14/2019Maxim GroupReiterated RatingBuy$8.00High
i
1/3/2019Northland SecuritiesReiterated RatingBuy$6.00High
i
9/18/2018Northland SecuritiesInitiated CoverageOutperform$6.00High
i
9/17/2018Northland SecuritiesInitiated CoverageOutperform$6.00High
i
8/14/2018Maxim GroupLower Price TargetBuy ➝ Buy$11.00 ➝ $8.00High
i
6/28/2018Maxim GroupInitiated CoverageBuy$11.00High
i
(Data available from 4/14/2016 forward)
Titan Medical logo
Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the SPORT Surgical System, a single-port robotic surgical system that comprises a surgeon-controlled patient cart, which includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The SPORT Surgical System enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and abdominal indications. Titan Medical Inc. is headquartered in Toronto, Canada.
Read More

Today's Range

Now: $1.70
$1.67
$1.71

50 Day Range

MA: $1.92
$1.68
$2.58

52 Week Range

Now: $1.70
$0.21
$3.47

Volume

1,001 shs

Average Volume

3,920,641 shs

Market Capitalization

$186.19 million

P/E Ratio

170.00

Dividend Yield

N/A

Beta

3.53

Frequently Asked Questions

What sell-side analysts currently cover shares of Titan Medical?

The following sell-side analysts have issued stock ratings on Titan Medical in the last twelve months: Oppenheimer Holdings Inc..
View the latest analyst ratings for TMDI.

What is the current price target for Titan Medical?

1 Wall Street analysts have set twelve-month price targets for Titan Medical in the last year. Their average twelve-month price target is $4.00, suggesting a possible upside of 136.7%. Oppenheimer Holdings Inc. has the highest price target set, predicting TMDI will reach $4.00 in the next twelve months. Oppenheimer Holdings Inc. has the lowest price target set, forecasting a price of $4.00 for Titan Medical in the next year.
View the latest price targets for TMDI.

What is the current consensus analyst rating for Titan Medical?

Titan Medical currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe TMDI will outperform the market and that investors should add to their positions of Titan Medical.
View the latest ratings for TMDI.

What other companies compete with Titan Medical?

How do I contact Titan Medical's investor relations team?

Titan Medical's physical mailing address is 155 UNIVERSITY AVENUE, TORONTO A6, M5H 3B7. The company's listed phone number is 416-548-7522. The official website for Titan Medical is www.titanmedicalinc.com.